Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies

Smoking-cessation therapy reduces the risk of smoking-related diseases, but is successful only in a fraction of smokers. There is growing evidence that genetic variations in nicotinic acetylcholine receptor (nAChR) subunits influence the risk of nicotine dependence and the ability to quit smoking. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Pintarelli, Giulia, Galvan, Antonella, Pozzi, Paolo, Noci, Sara, Pasetti, Giovanna, Sala, Francesca, Pastorino, Ugo, Boffi, Roberto, Colombo, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711795/
https://www.ncbi.nlm.nih.gov/pubmed/29196725
http://dx.doi.org/10.1038/s41598-017-16946-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711795/
https://www.ncbi.nlm.nih.gov/pubmed/29196725
http://dx.doi.org/10.1038/s41598-017-16946-6

Ejemplares similares